Integra Lifesciences Holdings Corp (IART)
23.58
+0.58
(+2.52%)
USD |
NASDAQ |
Nov 22, 16:00
23.55
-0.03
(-0.13%)
After-Hours: 20:00
Integra Lifesciences Holdings Cash from Financing (Quarterly): -19.92M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -19.92M |
June 30, 2024 | -93.75M |
March 31, 2024 | 358.68M |
December 31, 2023 | -6.89M |
September 30, 2023 | -49.66M |
June 30, 2023 | -10.69M |
March 31, 2023 | -162.68M |
December 31, 2022 | -97.70M |
September 30, 2022 | -7.642M |
June 30, 2022 | -13.15M |
March 31, 2022 | -133.46M |
December 31, 2021 | 0.521M |
September 30, 2021 | 1.743M |
June 30, 2021 | -97.48M |
March 31, 2021 | -3.015M |
December 31, 2020 | 21.22M |
September 30, 2020 | -33.05M |
June 30, 2020 | -28.55M |
March 31, 2020 | 162.00M |
December 31, 2019 | -81.99M |
September 30, 2019 | 81.02M |
June 30, 2019 | -13.19M |
March 31, 2019 | 5.393M |
December 31, 2018 | -84.06M |
September 30, 2018 | -39.84M |
Date | Value |
---|---|
June 30, 2018 | -36.09M |
March 31, 2018 | -20.89M |
December 31, 2017 | 664.21M |
September 30, 2017 | 286.37M |
June 30, 2017 | 33.32M |
March 31, 2017 | 185.04M |
December 31, 2016 | 13.76M |
September 30, 2016 | -19.80M |
June 30, 2016 | -19.03M |
March 31, 2016 | 9.952M |
December 31, 2015 | -17.76M |
September 30, 2015 | 245.31M |
June 30, 2015 | 34.42M |
March 31, 2015 | -13.83M |
December 31, 2014 | 7.638M |
September 30, 2014 | -13.19M |
June 30, 2014 | 1.062M |
March 31, 2014 | 243.17M |
December 31, 2013 | -0.488M |
September 30, 2013 | 0.184M |
June 30, 2013 | 19.07M |
March 31, 2013 | 0.257M |
December 31, 2012 | 2.817M |
September 30, 2012 | 0.46M |
June 30, 2012 | 21.03M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-162.68M
Minimum
Mar 2023
358.68M
Maximum
Mar 2024
-14.77M
Average
-16.53M
Median
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 7.00M |
Haemonetics Corp | -74.80M |
ResMed Inc | -150.76M |
Globus Medical Inc | 19.58M |
Perspective Therapeutics Inc | 0.628M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 22.48M |
Cash from Investing (Quarterly) | -10.40M |
Free Cash Flow | 38.04M |
Free Cash Flow Per Share (Quarterly) | -0.0937 |
Free Cash Flow to Equity (Quarterly) | 11.54M |
Free Cash Flow to Firm (Quarterly) | 0.3626M |
Free Cash Flow Yield | 2.08% |